First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults.

Autor: Prativadibhayankaram, Venkateshan S.¹ (AUTHOR), Lee, Lawrence Soon-U² (AUTHOR), Lye, David^2,3,4 (AUTHOR), Xiaoying, Xu² (AUTHOR), Nellore, Ranjani¹ (AUTHOR), Pendharkar, Vishal¹ (AUTHOR), Hentze, Hannes¹ (AUTHOR), Guan, Siyu⁵ (AUTHOR), Ayers, Benjamin J.⁵ (AUTHOR), Seah, Shirley G. K.⁶ (AUTHOR), Chye, De Hoe⁶ (AUTHOR), Talib, Najwa S. N.⁷ (AUTHOR), Kaliaperumal, Nivashini⁷ (AUTHOR), Ong, Wei Yee⁷ (AUTHOR), Wong, Zi Xin⁷ (AUTHOR), Au, Veonice B.⁷ (AUTHOR), Alok, Anshula⁷ (AUTHOR), Connolly, John E.^7,8 (AUTHOR), Boyd-Kirkup, Jerome D.⁵ (AUTHOR), Ingram, Piers J.⁵ (AUTHOR)

Publikováno v: Infectious Diseases & Therapy. Oct2022, Vol. 11 Issue 5, p1999-2015. 17p.